SCHEMBL9632673

SCHEMBL9632673

CCC1(C(=O)OC)CCCC(=O)C1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP4F2 P78329 1/20 0.41
CYP4A11 Q02928 1/20 0.41
MAPT P10636 2/20 0.37
KDM4E B2RXH2 1/20 0.37
ATM Q13315 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
CETP P11597 1/20 0.35
CYP2C19 P33261 5/20 0.34
CYP3A4 P08684 2/20 0.34
NPSR1 Q6W5P4 1/20 0.33
P2RX7 Q99572 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.31
THRB P10828 1/20 0.31
TSHR P16473 1/20 0.31
EED O75530 1/20 0.31
SUZ12 Q15022 1/20 0.31
EZH2 Q15910 1/20 0.31
HIF1A Q16665 1/20 0.31
EPAS1 Q99814 1/20 0.31
KCNA3 P22001 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18191201 0.81 CYP2C19 (0.38) CETPCYP2C19TSHRMEN1KMT2A
SCHEMBL27930089 0.79 CYP4F2 (0.39) CYP4F2CYP4A11MAPTKDM4EATM
SCHEMBL17155 0.78 CYP4F2 (0.56) CYP4F2CYP4A11MAPTL3MBTL1CETP
SCHEMBL17535 0.78 CYP4F2 (0.52) CYP4F2CYP4A11MAPTL3MBTL1CETP
SCHEMBL17857 0.76 CYP4F2 (0.55) CYP4F2CYP4A11MAPTL3MBTL1CETP
SCHEMBL5728819 0.75 CYP4F2 (0.36) CYP4F2CYP4A11MAPTKDM4EATM
SCHEMBL17106201 0.75 CYP4F2 (0.36) CYP4F2CYP4A11MAPTKDM4EATM
SCHEMBL17106199 0.75 CYP4F2 (0.36) CYP4F2CYP4A11MAPTKDM4EATM
SCHEMBL9631574 0.74 NPSR1 (0.36) CYP4F2CYP4A11KDM4ECYP2C19CYP3A4
SCHEMBL2285823 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5114960-A Rheumatoid arthritis; antiinflammatory and antishock agents; gastrointestinal and respiratory system disorders HOFFMANN-LA ROCHE INC. (US) 1992-05-19 US disclosed
EP-0409273-A2 Substituted isoxazole and isothiazole derivatives F. HOFFMANN-LA ROCHE AG (CH) 1991-01-23 EP disclosed